A pilot study suggests the diabetes medication pioglitazone is generally well tolerated and may warrant further study as a treatment for patients with Alzheimer's disease, according to a report posted online today that will ...

Medicine & Health - Neuroscience

Sep 13, 2010 not rated yet 0

Rosiglitazone, a drug used to treat type 2 diabetes, is associated with an increased risk of heart failure and death among older patients compared to a similar drug (pioglitazone), concludes a study published on BMJ.com today.

Medicine & Health - Medications

Aug 20, 2009 5 / 5 (2) 0